Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1)

Neda Moazzezy1, Elham Rismani2, Maryam Rezaei1

  • 1Molecular Biology Department, Pasteur Institute of Iran, Tehran, Iran.

Insights

Antimicrobial peptides (AMPs) combat antibiotic resistance by disrupting bacterial membranes. Modified human neutrophil peptide-1 (HNP-1) derivatives showed stable properties and similar interactions with lipid II, suggesting potential antimicrobial efficacy.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Drug Discovery

Background:

  • Rising antibiotic resistance necessitates novel antimicrobial strategies.
  • Antimicrobial peptides (AMPs), like human neutrophil peptide-1 (HNP-1), disrupt bacterial membranes.
  • Lipid II is a key target for AMPs, including HNP-1.

Purpose of the Study:

  • To computationally investigate the conformational and physicochemical properties of HNP-1 derived peptides.
  • To analyze the interaction patterns of these modified peptides with Lipid II.
  • To assess the potential of modified peptides as alternatives to native HNP-1.

Main Methods:

  • Homology modeling and geometrical validation of HNP-1.
  • Computational analysis of derived peptides (2Abz14S29, 2Abz23S29, HNP1ΔC18A) including stability and physicochemical properties.
  • Molecular docking and molecular dynamic simulations to study interactions with Lipid II.

Main Results:

  • Modified peptides 2Abz14S29 and 2Abz23S29 exhibited enhanced stability compared to HNP-1 and HNP1ΔC18A.
  • All studied peptides showed similar interaction patterns with Lipid II.
  • Binding affinity (Kd) for HNP-1 and 2Abz23S29 was significantly stronger than for 2Abz14S29 and HNP1ΔC18A.

Conclusions:

  • Computational studies indicate that chemically modified HNP-1 derivatives can retain antimicrobial activity.
  • Modifications improved physicochemical properties while maintaining essential interaction mechanisms with Lipid II.
  • These findings support the development of novel AMPs derived from HNP-1 for combating bacterial infections.

Related Concept Videos